JP2025500522A5 - - Google Patents
Info
- Publication number
- JP2025500522A5 JP2025500522A5 JP2024538472A JP2024538472A JP2025500522A5 JP 2025500522 A5 JP2025500522 A5 JP 2025500522A5 JP 2024538472 A JP2024538472 A JP 2024538472A JP 2024538472 A JP2024538472 A JP 2024538472A JP 2025500522 A5 JP2025500522 A5 JP 2025500522A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292859P | 2021-12-22 | 2021-12-22 | |
| US63/292,859 | 2021-12-22 | ||
| PCT/US2022/053705 WO2023122206A2 (en) | 2021-12-22 | 2022-12-21 | Multifuntional molecules binding to tcr and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025500522A JP2025500522A (ja) | 2025-01-09 |
| JP2025500522A5 true JP2025500522A5 (https=) | 2026-01-16 |
| JPWO2023122206A5 JPWO2023122206A5 (https=) | 2026-01-16 |
Family
ID=86903607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538472A Pending JP2025500522A (ja) | 2021-12-22 | 2022-12-21 | Ｔｃｒに結合する多機能性分子およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240409636A1 (https=) |
| EP (1) | EP4453039A4 (https=) |
| JP (1) | JP2025500522A (https=) |
| KR (1) | KR20240161975A (https=) |
| CN (1) | CN118786150A (https=) |
| AU (1) | AU2022419371A1 (https=) |
| CA (1) | CA3242160A1 (https=) |
| GB (1) | GB2631849A (https=) |
| WO (1) | WO2023122206A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3737692A4 (en) | 2018-01-09 | 2021-09-29 | Elstar Therapeutics, Inc. | CALRETICULIN AND MODIFIED T-LYMPHOCYTES BINDING CONSTRUCTIONS FOR THE TREATMENT OF DISEASES |
| EP3818083A2 (en) | 2018-07-03 | 2021-05-12 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| AU2020224681A1 (en) | 2019-02-21 | 2021-09-16 | Marengo Therapeutics, Inc. | Antibody molecules that bind to NKp30 and uses thereof |
| JP7710373B2 (ja) | 2019-02-21 | 2025-07-18 | マレンゴ・セラピューティクス，インコーポレーテッド | Ｔ細胞関連のがん細胞に結合する多機能性分子およびその使用 |
| CN116234829A (zh) | 2020-01-03 | 2023-06-06 | 马伦戈治疗公司 | 抗tcr抗体分子及其用途 |
| AU2024264260A1 (en) * | 2023-04-27 | 2025-11-13 | Marengo Therapeutics, Inc. | Combination therapies using molecules binding to tcr |
| WO2025049771A1 (en) * | 2023-08-30 | 2025-03-06 | Marengo Therapeutics, Inc. | Multifunctional molecules binding to tcr and uses thereof |
| WO2025147334A1 (en) * | 2024-01-05 | 2025-07-10 | Bright Biologics Llc | ANTI-c-MET/HER2 ANTIBODIES AND USES THEREOF |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001227966A1 (en) * | 2000-01-20 | 2001-07-31 | Chiron Corporation | Methods for treating tumors |
| WO2019035938A1 (en) * | 2017-08-16 | 2019-02-21 | Elstar Therapeutics, Inc. | MULTISPECIFIC MOLECULES BINDING TO BCMA AND USES THEREOF |
| CN116234829A (zh) * | 2020-01-03 | 2023-06-06 | 马伦戈治疗公司 | 抗tcr抗体分子及其用途 |
| GB2612450A (en) * | 2020-04-24 | 2023-05-03 | Marengo Therapeutics Inc | Multifunctional molecules that bind to T cell related cancer cells and uses thereof |
-
2022
- 2022-12-21 CN CN202280092392.1A patent/CN118786150A/zh active Pending
- 2022-12-21 WO PCT/US2022/053705 patent/WO2023122206A2/en not_active Ceased
- 2022-12-21 KR KR1020247024329A patent/KR20240161975A/ko active Pending
- 2022-12-21 AU AU2022419371A patent/AU2022419371A1/en active Pending
- 2022-12-21 EP EP22912450.8A patent/EP4453039A4/en active Pending
- 2022-12-21 JP JP2024538472A patent/JP2025500522A/ja active Pending
- 2022-12-21 GB GB2409147.2A patent/GB2631849A/en active Pending
- 2022-12-21 CA CA3242160A patent/CA3242160A1/en active Pending
-
2024
- 2024-06-21 US US18/749,969 patent/US20240409636A1/en active Pending